Home / Stocks / LENZ

LENZ insider trading

LENZ Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
5
Bought · 24 mo
$655k
Buys · last 90 days
0 · $0
Most recent buy
2026-03-30

Cluster buy detected

3 insiders bought LENZ within a short window (2026-03-27), $366k in total — cluster score 62/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-03-30George Jeffrey P.cluster
Director
Bought5,592$8.92$50k
2026-03-30Schimmelpennink Evert B.cluster
President, CEO and Secretary
Bought28,089$8.95$251k
2026-03-30Chevallard Daniel R.cluster
Chief Financial Officer
Bought7,500$8.57$64k
2025-11-10MCCOLLUM JAMES W
Director
Bought10,500$22.79$239k
2025-11-07Chevallard Daniel R.
Chief Financial Officer
Bought2,198$22.76$50k
2025-10-02Versant Vantage II GP, L.P.
10% owner
Sold224,674$46.01$10.3M
2025-09-22Versant Vantage II GP, L.P.
10% owner
Sold114,756$42.09$4.8M
2025-08-26Versant Vantage II GP, L.P.
10% owner
Sold94,248$39.27$3.7M
2025-08-19Versant Vantage II GP, L.P.
10% owner
Sold245,628$39.38$9.7M
2025-07-14Versant Vantage II GP, L.P.
10% owner
Sold191,376$34.00$6.5M
2025-07-01Versant Vantage II GP, L.P.
10% owner
Sold200,000$30.47$6.1M
2025-06-20Versant Vantage II GP, L.P.
10% owner
Sold334,801$30.19$10.1M
2025-06-12Versant Vantage II GP, L.P.
10% owner
Sold350,000$29.00$10.2M

Most active insider buyers

InsiderRoleBuysTotal bought
Schimmelpennink Evert B.President, CEO and Secretary1$251k
MCCOLLUM JAMES WDirector1$239k
Chevallard Daniel R.Chief Financial Officer2$114k
George Jeffrey P.Director1$50k

See LENZ on the chart

Every insider buy and sell for LENZ plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.